During reorganization of its R & D organization, Takeda Pharmaceutical span out in April Axcelead Drug Discovery Partners, a 100 % subsidiary targeting drug discovery support projects such as exploration, screening, optimization, medicinal pharmacology, pharmacokinetics and safety evaluation of new drugs. 250 employees were transferred to the subsidiary. The new company will participate in open innovation accepting projects from venture companies and academia.

Takeda news release, July 10, 2107